Business
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health
About this update from Envoy Medical, Inc.
[{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) (\"Envoy Medical\" or the \"Company\"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of three new patents with one in the United States and two in Hong Kong, further expanding its intellectual property and reinforcing its competitive position in the cochlear implant industry.\n\"We believe the future of the cochlear implant industry is fully implanted devices and that our approach is novel when compared to other designs,\" said Brent Lucas, Chief Executive Officer of Envoy Medical. \"As the industry realizes the wisdom and flexibility of our approach, we will have a strong patent portfolio to help protect our leadership position as a first mover with substantial differentiation.\"\nManagement believes that as the Company progresses toward potential Premarket Approval (PMA) submission and commercialization, the strength and breadth of its intellectual property portfolio will be an increasingly important asset, both strategically and competitively.\nThe United States Patent and Trademark Office granted U.S. Patent No. 12,544,564 on February 10, 2026, titled \"Cochlear Implant System with Improved Input Signal-to-Noise Ratio.\" This patent relates to cochlear implant systems having a signal processor configured to filter a received input signal to attenuate a first pulse rate in the input signal and to output a stimulation signal based on the filtered input signal to cause a stimulator to provide electrical stimulation at the first pulse rate.\nIn addition, the Hong Kong Patent Office granted two complementary patents. Hong Kong Patent No. HK40102155, titled \"Combination Hearing Aid and Cochlear Implant System.\" This patent relates to cochlear implant systems and receiving a status indicator signal indicative of whether an external auditory aid device (e.g., a hearing aid) is active and updating a transfer function of a signal processor of the cochlear implant system to compensate for operation of the external auditory aid device if it is active. This capability relates to the potential flexibility allowed by our system by leveraging the natural ear to pick up sound, which allows for (but does not require) the use of other devices in the ear.\nHong Kong Patent No. HK40107235,...